Category:Christchurch_HospitalChristchurch_HospitalChristchurch_HospitalHospital_de_Christchurch%D0%93%D0%BE%D1%81%D0%BF%D0%B8%D1%82%D0%B0%D0%BB%D1%8C_%D0%9A%D1%80%D0%B0%D0%B9%D1%81%D1%82%D1%87%D0%B5%D1%80%D1%87%D0%B0%D0%93%D0%BE%D1%81%D0%BF%D1%96%D1%82%D0%B0%D0%BB%D1%8C_%D0%9A%D1%80%D0%B0%D0%B9%D1%81%D1%82%D1%87%D0%B5%D1%80%D1%87%D0%B0Q1278898
about
Dinutuximab in Combination With Sargramostim in Treating Patients With Recurrent OsteosarcomaCombination Chemotherapy With or Without Temsirolimus in Treating Patients With Intermediate Risk RhabdomyosarcomaTAXUS PERSEUS WorkhorseEvaluation of Efficacy and Safety of Peramivir in Adults With Acute Serious or Potentially Life-threatening InfluenzaPhase 1 Study of BHT-3021 in Subjects With Type 1 Diabetes MellitusCombination Chemotherapy With or Without Gemtuzumab in Treating Young Patients With Newly Diagnosed Acute Myeloid LeukemiaA Study of the TAXUS Liberté Stent for the Treatment of de Novo Coronary Artery Lesions in Small VesselsTAXUS ATLAS: TAXUS Liberté™-SR Stent for the Treatment of de Novo Coronary Artery LesionsA Study of the TAXUS Liberté Stent for the Treatment of Long De Novo Coronary Artery LesionsDirect Stenting of TAXUS Liberté™-SR Stent for the Treatment of Patients With de Novo Coronary Artery LesionsMaintenance Chemotherapy or Observation Following Induction Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed EpendymomaThird International Study on Mechanical VentilationLong-Term Study Of CP-690,550 In Subjects With Ulcerative ColitisA Study To Evaluate Both The Efficacy and Safety Profile of CP-690,550 In Patients With Moderately to Severely Active Ulcerative ColitisA Study Of Oral CP-690,550 As A Maintenance Therapy For Ulcerative ColitisA Gilead Sequence Registry of Subjects Who Did Not Achieve Sustained Virologic ResponseGilead Sustained Virologic Response (SVR) RegistryADjunctive coRticosteroid trEatment iN criticAlly ilL Patients With Septic ShockPhase II Study of AS1411 Combined With Cytarabine to Treat Acute Myeloid LeukemiaRadiotherapy - Adjuvant Versus Early SalvageRituximab in Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Follicular Non-Hodgkin's LymphomaAndrogen Deprivation Therapy in Treating Patients With Prostate CancerCombination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic LeukemiaComparison of Radiation Therapy Regimens in Combination With Chemotherapy in Treating Young Patients With Newly Diagnosed Standard-Risk MedulloblastomaCisplatin and Combination Chemotherapy in Treating Children and Young Adults With Hepatoblastoma or Liver Cancer After SurgerySafety/Efficacy of Q-122 in Breast Cancer Patients Taking Tamoxifen or Aromatase InhibitorILUMIEN IV: OPTIMAL PCIBAsel Syncope EvaLuation (BASEL IX) StudyPhase 3 Study of Sofosbuvir and RibavirinStudy of Pralatrexate Versus Observation Following CHOP-based Chemotherapy in Previously Undiagnosed Peripheral T-cell Lymphoma PatientsA Trial in Adults With Type 1 Diabetes Mellitus Evaluating the Effects of Fenofibrate Versus Placebo on Macular Thickness and VolumeClinical Investigation of the MiStent Drug Eluting Stent (DES) in Coronary Artery DiseaseCAROLINA: Cardiovascular Outcome Study of Linagliptin Versus Glimepiride in Patients With Type 2 DiabetesCombination Chemotherapy in Treating Patients With Non-Metastatic Extracranial Ewing SarcomaExtravascular ICD Pilot StudyDynamX Sirolimus StudySirolimus Eluting Coronary Bioadaptor SystemComparing the Pharmacokinetics of Nicotine Salt Based ENDS in Healthy SmokersPragmatic Randomised Trial of High Or Standard PHosphAte Targets in End-stage Kidney Disease (PHOSPHATE)CANTATA: CB-839 With Cabozantinib vs. Cabozantinib With Placebo in Patients With Metastatic Renal Cell CarcinomaA Trial to Demonstrate the Equivalent Pharmacokinetic Properties of HD204 and Bevacizumab (Avastin®) in Healthy Male Subjects
P6153
Q42707877-28533A82-72F5-4358-A7A2-D00231B8BB11Q55590598-FA15B26C-44F6-400C-B018-9C65A8DFC706Q61839783-CDC4766F-92FB-48D3-A418-5B11090BFD12Q7781089-D42C54A0-5F2F-4F6B-A544-69DE9EAAD0EBQ80605694-E06DA89C-AE45-484A-84D2-E2EC83FC9B0DQ81048482-CC03750B-D318-4326-9AE6-DEBED6DE9A21Q83436569-DCB4FD9B-696B-4675-BEB4-E9D1CBBBD32CQ83983188-071C3416-C4EC-4D45-B1F3-A77C910D7513Q85651773-6FDF57FD-81D5-49F6-926F-A25D9915C414Q85651773-C7A0D645-C31F-46D6-A4CF-D0CF7F521CCFQ87770125-F536D366-991B-4855-8F46-26453756EE86Q87956504-E4BF87C9-F75E-4073-8E3B-63AE556262C9
P108
Q58407636-1DD76713-474C-4744-BA8D-B144E6860538Q61862239-D065E147-B307-4D84-A4FF-4F24544F30F5Q61918610-A8D9B056-8735-4D7E-9310-7EA3FAF4A60EQ61920750-B22ADE72-F32F-4A36-99DB-9C565B4C1E5CQ61920803-6391F8C2-3DA9-4862-9421-1C1A8A697D65Q61932952-6713309D-73C3-4419-9600-B9C06DDE499BQ61933101-A49F9D2B-711C-4AAB-B7C7-819F78027723Q61933107-A669F1A2-4ABB-41FB-AFDD-2ABDB3F12188Q61933152-1FAB745B-0F39-4CCD-A80A-A952078354CEQ61933160-F3B8E619-9C5B-4A4B-84F0-E1D639ECBF63Q61936459-B9A32B63-0E9B-4671-A80A-14816BB6445AQ61936877-A595C9D3-1986-4F75-BDA4-A14C4D5E8A0BQ61955644-98A946C7-ADE5-4FC1-8750-F0ECF721D960Q61965830-FBD98781-7DF0-41D5-83E9-9ACE5A25F4E2Q61965863-FD47454A-DC9E-4F7A-8F89-D2DE506F72E4Q61965936-3419DE41-18F6-46D5-BFFD-5E8347C49C39Q61965937-E0FA2C3B-F131-45F1-AED7-C85EF0DCEB2AQ61967814-35DCC75B-10A2-4C94-AA71-E925D06BC46AQ61979062-C74542DD-5DC1-4B53-9880-FBD6A043410EQ61981481-0E0B02D1-B15E-48B4-9F0C-CFAE5357B4F4Q62105008-785A4A19-03A1-4DFE-9246-1AF85255278EQ62105292-858E732D-262A-42F9-819F-180B6DC9C289Q62106060-E3A32DB7-AAD2-4150-948B-06F2A2062C9DQ62110645-A0C8E80B-5807-4B74-8208-65A1E3190BECQ62815257-A2FA4CBD-5C7E-447F-B7F2-CDACAE030B5AQ62817242-3BE7966F-D966-46E7-8229-CFD14FA2E598Q62822345-6E2FC3AB-A7FF-4689-B903-FD5CC0A07CEFQ63316416-E214EAE0-6002-404B-B1E0-1AB530D962F7Q63318807-4A15C62F-25D4-4E04-82FD-C8F3BEA0EE12Q63322234-7A1E70FF-3568-4992-B416-FFA3498DE39AQ63336608-235A0122-C038-481A-A64A-BDE288E21FA5Q63339341-873DA05B-876F-4202-AD92-BDBEE6315AFAQ63340041-610F0210-F295-4444-A15A-368C250C86EDQ63341046-B416287F-A17C-4B80-B92F-87E0E0E815DAQ63394128-2EA93F3B-4731-4389-ACD1-B8DE98333FD4Q63394445-2BC64A56-8A54-440E-86BD-D4732988F564Q63395038-59FDA06F-7D00-4A6D-B295-BB65A8CF6557Q63397080-EEB44B5F-E904-49B5-B942-E0B6AC54A4F2Q63404887-40BED830-EEA5-47FD-A76F-45A0D67473A8Q63405192-5C0328FB-348E-47A2-9369-81F1AD0C1784
P6153
description
Krankenhaus
@de
griya sakit
@jv
hastane
@tr
hospital de Nueva Zelanda
@ast
hospital in New Zealand
@en
hôpital
@fr
rumah sakik
@min
rumah sakit di Selandia Baru
@id
rumoh sakét
@ace
ziekenhuis in Nieuw-Zeeland
@nl
name
Christchurch Hastanesi
@tr
Christchurch Hospital
@de
Christchurch Hospital
@de-ch
Christchurch Hospital
@en
Christchurch Hospital
@en-ca
Christchurch Hospital
@en-gb
Christchurch Hospital
@fr
Christchurch Hospital
@id
Christchurch Hospital
@nl
Hospital de Christchurch
@es
type
label
Christchurch Hastanesi
@tr
Christchurch Hospital
@de
Christchurch Hospital
@de-ch
Christchurch Hospital
@en
Christchurch Hospital
@en-ca
Christchurch Hospital
@en-gb
Christchurch Hospital
@fr
Christchurch Hospital
@id
Christchurch Hospital
@nl
Hospital de Christchurch
@es
altLabel
Christchurch Hospital
@tr
Больница Крайстчёрча
@ru
基督城医院
@zh
prefLabel
Christchurch Hastanesi
@tr
Christchurch Hospital
@de
Christchurch Hospital
@de-ch
Christchurch Hospital
@en
Christchurch Hospital
@en-ca
Christchurch Hospital
@en-gb
Christchurch Hospital
@fr
Christchurch Hospital
@id
Christchurch Hospital
@nl
Hospital de Christchurch
@es
P214
P244
P6366
P17
P213
0000 0004 0614 1349
P214
P2427
grid.414299.3
P244
no2005100586
P3417
Christchurch-Hospital
P3500
P373
Christchurch Hospital
P571
1862-01-01T00:00:00Z
P625
Point (172.626 -43.5344)
P6366
2802773633
P6782
P7859
lccn-no2005100586